News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BasicResearch’ clear

  • Evidence suggests normal cells in bone marrow reduce cancerous cells' ability to undergo apoptosis.

Tags: BasicResearch

  • A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston

Tags: BasicResearch, Radiation

  • An analysis of two dozen clinical studies finds most adults with poor-risk and intermediate-risk acute myeloid leukemia benefit from allogeneic stem cell transplants.

Tags: BasicResearch, StemCellTransplant, Leukemia

  • A section of the AIDS virus's protein envelope known as the V3 loop and once considered an improbable target for a vaccine now appears to be one of the most promising, according to research authored by Dana-Farber's Ruth Ruprecht, MD, PhD.

Tags: BasicResearch, ImmuneSystem

  • Although it sounds like a case of gender confusion on a molecular scale, the male hormone androgen spurs the growth of some breast tumors in women. In a new study, scientists at Dana-Farber Cancer Institute provide the first details of the cancer cell machinery that carries out the hormone’s relentless growth orders.

Tags: BasicResearch, BreastCancer

  • Scientists at Dana-Farber Cancer Institute and the University of Colorado Cancer Center report on a gene fusion that spurs the cells to divide rapidly. Treating the cells with a compound that blocks the protein caused the cells to die which may offer a targeted therapy in patients.

Tags: BasicResearch, LungCancer

  • Dana-Farber researchers suggest guidelines and provide tools to minimize inconsistencies in collecting and sharing data on interactions between cell proteins.

Tags: BasicResearch

  • Dana-Farber/Harvard Cancer Center researchers receive six Specialized Program of Research Excellence (SPORE) grants, which support research that moves from the laboratory to the clinic.

Tags: BasicResearch, Grants

  • Dana-Farber scientists find when given together, two orally available experimental drugs – sapacitabine and seliciclib – worked together to elicit antitumor effects in patients with incurable BRCA-deficient cancers.

Tags: BasicResearch, BreastCancer, PancreaticCancer, GynecologicCancers

  • In prostate cancer patients with a certain genetic variant, a high level of selenium in the blood was associated with a two-fold greater risk of poorer outcomes than men with the lowest amounts of selenium.

Tags: BasicResearch, ProstateCancer

Showing 11-20 of 111 items